Resources

We conducted a longitudinal follow-up study examining OAT-related experiences among federally incarcerated individuals before and after community release.

Some critics contend that naloxone expansion may inadvertently promote high-risk substance use behaviors among adolescents, but this question has not been directly investigated.

This study aimed to establish factors influencing the successful design and implementation of drug alerts for use in clinical and community service settings in Victoria, Australia.

Our objective in this research was to examine if, and how, disruptions to illicit opioid markets related to Covid-19 have affected people who use illicit opioids.

Our primary objective was to examine trends in amphetamine-related ED visits over time in Ontario, including by age and sex.

This study explored the use of tiered mentoring opportunities within an ECHO® model to expand treatment capacity and develop a statewide network of medications for OUD (MOUD) expertise.

The current study explores stakeholders’ perspectives on the feasibility and acceptability of vending machines for harm reduction (VMHR) in Philadelphia.

This study estimates the prevalence of prescription opioid use (POU) in the United States (US) in 2019–2020, both in the general population and specifically among adults with pain.

To better understand the impact of the pandemic on medication for opioid use disorder (MOUD) services in the U.S.

This qualitative narrative synthesis sought to identify pathways connecting socioeconomic marginalization (SEM) and overdose for people who use drugs.

Unregulated drug markets lead to samples with unexpected and variable contents. A retrospective data analysis of Zurich's DCS was performed to determine the nature of these samples.

We conducted this study to understand the rural context and factors that affected access of TiOAT programs.

We conducted an environmental scan to provide an overview of current organizational practices and characteristics of withdrawal management services (WMS) in Canadian substance use treatment systems

We assessed the psychometrics of a novel COVID-19 response-related discrimination scale among PWID, and characterized associations between COVID-19 response-related discrimination, resilience to ad

A clinical trial of a new OAT, depot buprenorphine provided the opportunity to obtain health and correctional staff perspectives regarding this treatment prior to widespread roll-out.

This study sought to understand how adaptations in the complex system of OAT provision impacted and responded to risk environments of people receiving OAT during the COVID-19 pandemic.